Weight loss medications like Zepbound are not recommended during pregnancy and should be discontinued when pregnancy is recognized
Flow Wellness does not claim affiliation with or endorsement by Novo Nordisk or Eli Lilly.
This is always a clinical decision, but some patterns have emerged in the way providers describe their prescribing preferences: Tirzepatide tends to be preferred for patients seeking maximum weight loss, patients with type 2 diabetes (where the dual mechanism helps glycemic control), and patients who have not responded adequately to semaglutide

Across this research, we found that: - Many participants substantially reduced their stimulant use despite not achieving abstinence ( - These reductions were associated with significant improvements in craving, depression, drug-seeking behaviors, and psychosocial functioning ( - Our latest study demonstrated that measuring reductions in stimulant use can identify meaningful treatment benefits that may be missed when abstinence is used as the sole outcome ( By pooling data from 12 NIDA-funded randomized clinical trials, this latest study provides further evidence that reduced stimulant use is a clinically meaningful, patient-centered outcome for evaluating pharmacotherapies
2 % is the sweet spot for most patients